EGFR tyrosine kinase inhibitor (TKI) plus chemotherapy vs chemotherapy alone
Toxicity: grade 3 or 4 fatigue · treatment of relapsed epithelial ovarian cancer
It is very uncertain whether EGFR tyrosine kinase inhibitor (TKI) plus chemotherapy changes toxicity: grade 3 or 4 fatigue compared with chemotherapy alone (very low certainty).
1 finding from 1 review
- Epidermal growth factor receptor blockers for the treatment of ovarian cancer 2018 · Cochrane Headline outcomes onlyRR 0.87 [0.28, 2.72]1 study · 125 participantsVery low